This guideline covers managing neuropathic pain (nerve pain) with pharmacological treatments (drugs) in adults in non-specialist settings. It aims to improve quality of life for people with conditions such as neuralgia, shingles and diabetic neuropathy by reducing pain and promoting increased participati...
The case for adopting Neuropad to detect preclinical diabetic peripheral neuropathy is not supported by the evidence. Neuropad detects sub-normal sweating in patients with diabetes but the clinical importance of this in current NHS care pathways is poorly defined. There is insufficient evidence to suppor...
This guideline covers managing neuropathic pain (nerve pain) with pharmacological treatments (drugs) in adults in non-specialist settings. It aims to improve quality of life for people with conditions such as neuralgia, shingles and diabetic neuropathy by reducing pain and promoting increased participati...
Arthropathy, Neurogenic/drug therapy,
Neuralgia/drug therapy,
Herpes Zoster/drug therapy,
Diabetic Neuropathies/drug therapy,
Amitriptyline/therapeutic use,
Duloxetine Hydrochloride/therapeutic use,
Tramadol/therapeutic use,
Capsaicin/therapeutic use,
Quality of Life,
Health Promotion
El objetivo general de esta GPC es proporcionar orientación sobre las diversas alternativas de los cuidados que se proporcionan a las personas con DM1, estableciendo recomendaciones basadas en la evidencia mas relevante y actual. También se pretende desarrollar estándares que puedan maximizar la calid...
Diabetes Mellitus, Type 1/complications,
Diabetes Mellitus, Type 1/diagnosis,
Diabetes Mellitus, Type 1/drug therapy,
Insulin, Regular, Human/therapeutic use,
Insulin Glargine/therapeutic use,
Insulin Detemir/therapeutic use,
Diabetic Foot/prevention & control,
Diabetic Neuropathies/prevention & control,
Risk Factors,
Critical Pathways/organization & administration
